Mirova’s Novo Nordisk NVO Stock Holding History

Mirova’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,932	Closed	-$50K	–	186
2019 Q3	$50K	Hold	1,932	–	–	0.01%	115
2019 Q2	$49K	Buy	+1,932	New	+$47.7K	﹤0.01%	116

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Mirova's NVO Position: Q4 2019 in Review

Mirova sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 1,932 shares — an estimated $50K sold.

Mirova first reported a position in NVO in Q2 2019 and held it in 2 quarters. The position peaked at $50K in Q3 2019. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

Mirova reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
Mirova sold 1,932 Novo Nordisk shares in Q4 2019, an estimated $50K.
Mirova first reported a position in Novo Nordisk in Q2 2019 and held it in 2 quarters.
Mirova's Novo Nordisk position peaked at $50K in Q3 2019.
640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Mirova's 13F filing for Q4 2019, filed 14 Feb 2020.